Works matching IS 0012186X AND DT 2024 AND VI 67 AND IP 1


Results: 23
    1
    2
    3

    Up Front.

    Published in:
    Diabetologia, 2024, v. 67, n. 1, p. 1, doi. 10.1007/s00125-023-06059-3
    Publication type:
    Article
    4
    5
    6
    7

    Apolipoprotein L genes are novel mediators of inflammation in beta cells.

    Published in:
    Diabetologia, 2024, v. 67, n. 1, p. 124, doi. 10.1007/s00125-023-06033-z
    By:
    • Paz-Barba, Miriam;
    • Muñoz Garcia, Amadeo;
    • de Winter, Twan J. J.;
    • de Graaf, Natascha;
    • van Agen, Maarten;
    • van der Sar, Elisa;
    • Lambregtse, Ferdy;
    • Daleman, Lizanne;
    • van der Slik, Arno;
    • Zaldumbide, Arnaud;
    • de Koning, Eelco J. P.;
    • Carlotti, Françoise
    Publication type:
    Article
    8
    9
    10
    11

    Multi-omic prediction of incident type 2 diabetes.

    Published in:
    Diabetologia, 2024, v. 67, n. 1, p. 102, doi. 10.1007/s00125-023-06027-x
    By:
    • Carrasco-Zanini, Julia;
    • Pietzner, Maik;
    • Wheeler, Eleanor;
    • Kerrison, Nicola D.;
    • Langenberg, Claudia;
    • Wareham, Nicholas J.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    The metabolic potential of inflammatory and insulinaemic dietary patterns and risk of type 2 diabetes.

    Published in:
    Diabetologia, 2024, v. 67, n. 1, p. 88, doi. 10.1007/s00125-023-06021-3
    By:
    • Lee, Dong Hoon;
    • Jin, Qi;
    • Shi, Ni;
    • Wang, Fenglei;
    • Bever, Alaina M.;
    • Liang, Liming;
    • Hu, Frank B.;
    • Song, Mingyang;
    • Zeleznik, Oana A.;
    • Zhang, Xuehong;
    • Joshi, Amit;
    • Wu, Kana;
    • Jeon, Justin Y.;
    • Meyerhardt, Jeffrey A.;
    • Chan, Andrew T.;
    • Eliassen, A. Heather;
    • Clish, Clary;
    • Clinton, Steven K.;
    • Giovannucci, Edward L.;
    • Li, Jun
    Publication type:
    Article
    18
    19
    20

    A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.

    Published in:
    Diabetologia, 2024, v. 67, n. 1, p. 27, doi. 10.1007/s00125-023-06014-2
    By:
    • Mathieu, Chantal;
    • Wiedeman, Alice;
    • Cerosaletti, Karen;
    • Long, S. Alice;
    • Serti, Elisavet;
    • Cooney, Laura;
    • Vermeiren, Joan;
    • Caluwaerts, Silvia;
    • Van Huynegem, Karolien;
    • Steidler, Lothar;
    • Blomme, Sven;
    • Rottiers, Pieter;
    • Nepom, Gerald T.;
    • Herold, Kevan C.
    Publication type:
    Article
    21

    ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis.

    Published in:
    Diabetologia, 2024, v. 67, n. 1, p. 170, doi. 10.1007/s00125-023-06010-6
    By:
    • Chhabra, Kavaljit H.;
    • Bathina, Siresha;
    • Faniyan, Tumininu S.;
    • Samuel, Dennis J.;
    • Raza, Muhammad Ummear;
    • de Souza Cordeiro, Leticia Maria;
    • Viana Di Prisco, Gonzalo;
    • Atwood, Brady K.;
    • Robles, Jorge;
    • Bainbridge, Lauren;
    • Davis, Autumn
    Publication type:
    Article
    22
    23